{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Original text with changes shown', 'New wording', 'Reason/Justifi', 'cation for', 'change', 'YGTSS questionnaire should be performed', 'should be directed to the child,', 'before any blood draws or ECG', 'but the caregiver/adult should be', 'assessments.):', 'encouraged to add relevant', 'information. The YGTSS', 'questionnaire should be', 'performed before any blood', 'draws or ECG assessments.):', '3.13.1.1. YGTSS Rater Certification', '3.13.1.1. YGTSS Rater Certification', 'This section', '3.13.1.1. YGTSS Rater Certification', 'was added for', 'All investigators and subinvestigators who will', 'All investigators and', 'instruction', 'be administering the YGTSS from screening', 'subinvestigators who will be', 'related to', 'through the end of study visit must undergo and', 'administering the YGTSS from', 'protocol', 'pass a Rater Certification Program which will', 'screening through the end of study', 'specific', 'visit must undergo and pass a Rater', 'be provided separately from this protocol. Every', 'YGTSS rater', 'Certification Program which will be', 'certification.', 'effort must be made to ensure that the same', 'provided separately from this', 'certified rater administers the YGTSS to a', 'protocol. Every effort must be made', 'specific patient at all visits, especially at the', 'to ensure that the same certified', 'baseline and week 12/early termination visits.', 'rater administers the YGTSS to a', 'However, if due to unforeseen circumstances', 'specific patient at all visits,', 'the same rater is absolutely unavailable to', 'especially at the baseline and week', 'complete a visit rating, the YGTSS can be', '12/early termination visits.', 'administered only by another certified', 'However, if due to unforeseen', 'individual from that study site.', 'circumstances the same rater is', 'absolutely unavailable to complete a', 'visit rating, the YGTSS can be', 'administered only by another', 'certified individual from that study', 'site.', '3.13.2. Procedures before IMP Treatment (Baseline/Day 1) (Other sections affected by this change:', '3.13.3.1.2., 3.13.3.2.1., 3.13.3.2.2., 3.13.4.1.)', 'administer the following questionnaires', 'administer the following', 'Specific', 'instruction was', '(Note: For C-SSRS,', 'questionnaires (Note: For C-', 'provided for', 'and GTS-QOL, children 13 years', 'SSRS,', 'the YGTSS,', 'of age and under must be interviewed in', 'and GTS-QOL,', 'TS-CGI, and', 'conjunction with the caregiver/adult. For', 'children 13 years of age and', 'children over 13 years of age, caregiver/adult', 'under must be interviewed in', 'assessments to', 'involvement is strongly encouraged.', 'conjunction with the', 'be performed', 'Questions should be directed to the child, but', 'caregiver/adult. For children over', 'before any', 'the caregiver/adult should be encouraged to', '13 years of age, caregiver/adult', 'blood draws or', 'add relevant information. The YGTSS, TS-', 'involvement is strongly', 'ECG.', 'CGI, and', 'questionnaires should be', 'encouraged. Questions should be', 'performed before any blood draws or ECG', 'directed to the child, but the', '123']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Original text with changes shown', 'New wording', 'Reason/Justifi', 'cation for', 'change', 'assessments.):', 'caregiver/adult should be', 'encouraged to add relevant', 'information. The YGTSS, TS-', 'CGI, and', 'questionnaires', 'should be performed before any', 'blood draws or ECG', 'assessments.):', '4.1 Patient Inclusion Criteria', 'j. Females may be included only if they have', 'j.', 'Females may be included only if', 'Additional', 'a negative \u00df-HCG test at baseline or are sterile.', 'they have a negative \u00df-HCG test at', 'inclusion', 'Definitions of sterile given in Appendix L.', 'baseline or are sterile. Definitions of', 'criteria for', 'k. Females of childbearing potential whose', 'sterile given in Appendix L.', 'females were', 'male partners are potentially fertile (ie, no', 'k. Females of childbearing', 'added to', 'vasectomy) must use highly effective birth', 'potential whose male partners are', 'include \u00df-HCG', 'control methods for the duration of the study', 'potentially fertile (ie, no vasectomy)', 'test and the', '(ie, starting at screening) and for 30 days or 5', 'must use highly effective birth', 'requirement to', 'half-lives, whichever is longer after last dose of', 'control methods for the duration of', 'use highly', 'IMP. Further details are included in Appendix', 'the study (ie, starting at screening)', 'effective birth', 'L.', 'and for 30 days or 5 half-lives,', 'control', 'whichever is longer after last dose', 'methods.', 'of IMP. Further details are included', 'in Appendix L.', '4.2 Patient Exclusion Criteria', 'm. Patient has a QT interval corrected for heart', 'm. Patient has a QT interval', 'The exclusion', \"rate using Frederica's formula (QTcF) interval\", 'corrected for heart rate using', 'criteria were', 'value >4450 msec (males) or >460 msec', \"Frederica's formula (QTcF) interval\", 'modified to', '(females) or >480 msec (with right bundle', 'value >450 msec (males) or >460', 'define criteria', 'branch block) on 12-lead ECG at screening.', 'msec (females) or >480msec (with', 'for QTc.', 'n. Patients with a history of torsade de pointes,', 'right bundle branch block) on 12-', 'congenital long QT syndrome,', 'lead ECG at screening.', 'bradyarrhythmias, or uncompensated heart', 'n. Patients with a history of', 'failure.', 'torsade de pointes, congenital long', 'QT syndrome, bradyarrhythmias, or', 'uncompensated heart failure.', '4.2 Patient Exclusion Criteria', 's.t. The pPatient is a pregnant or lactating', 't.', 'The patient is a pregnant or', 'Wording of', 'female, breastfeeding or plans to become', 'lactating female, or plans to become', 'patient', 'pregnant during the study.', 'pregnant during the study.', 'exclusion', 'criteria', 'regarding', 'pregnancy or', 'lactation was', '124']\n\n###\n\n", "completion": "END"}